Therapeutics

Top Story

High cholesterol levels increase risk of primary open-angle glaucoma

August 28, 2019

Read the Perspective from Mark Eltis, OD, FAAO

In the JournalsPerspective

Cyclosporine-chondroitin improves dry eye signs, symptoms in ongoing trial

August 13, 2019
Preliminary study results show significant improvement in dry eye questionnaire scores, subjective symptoms and corneal staining in patients with using 0.1% cyclosporine…
Meeting News

Tivanisiran improves discomfort, hyperemia in patients with dry eye

August 2, 2019
VANCOUVER, British Columbia – Results from phase 2 and phase 3 trials showed that tivanisiran 1.125% significantly improved ocular discomfort/pain and conjunctival…
In the JournalsPerspective

DNase drops show promise in reducing dry eye symptoms

July 18, 2019
Recombinant deoxyribonuclease eye drops show potential in reducing both the signs and severity of dry eye in patients with severe tear-deficient dry eye disease…
More Headlines »
COPE

Visual Reality: Diabetic Retinopathy

This activity is supported by independent medical education grants from Optos North America and Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy (DR) continues to be a leading cause of blindness. However, early diagnosis and prompt treatment…
More »
Video
Meeting News

VIDEO: Multiple microbypass stents control IOP better

June 28, 2018
More »
Video
Meeting News

VIDEO: New brand of loteprednol has increased penetration

March 22, 2019
More »